| Number: 201204071 |
Principal Investigator: Wagner-Johnston, Nina |
| Title: A Phase I/II Institutional Study of Abraxane in Recurrent and Refractory Lymphoma |
| Description: The purpose of this research study is to find the maximum tolerated dose for Abraxane as well as discover what side effects are associated with its use in patients with lymphoma and how the disease responds to Abraxane....MORE |
| ___________________________________________________________________________________________________ |
| Number: 201010719 |
Principal Investigator: Fehniger, Todd |
| Title: A Pilot Study of Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Hodgkin Lymphoma |
| Description: The purpose of this research study is to gather information about lenalidomide maintenance therapy in patients with classical Hodgkin lymphoma....MORE |
| ___________________________________________________________________________________________________ |
| Number: 201110234 |
Principal Investigator: Bartlett, Nancy |
| Title: A Phase II Trial of Panobinostat and lenalidomide in Patients with Relapsed or Refractory Hodgkin's Lymphoma |
| Description: The goal of this clinical research study is to find out the effects of the drugs called panobinostat and lenalidomide when given in combination to people with Hodgkin’s lymphoma. The safety of this combination of drugs will also be studied....MORE |
| ___________________________________________________________________________________________________ |
| Number: CALGB 50801 |
Principal Investigator: Bartlett, Nancy |
| Title: Phase II Trial of Response-Adapted Therapy Based on Position Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL) |
| Description: The purpose of this study is to find out if we can safely reduce the total number of cycles of chemotherapy that patients will need for their Hodgkin lymphoma based on their response during treatment as seen on positron emission tomography (PET) scan images.
This research is being done in order ...MORE |
| ___________________________________________________________________________________________________ |
| Number: 201210128 |
Principal Investigator: Bartlett, Nancy |
| Title: A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma (C25003) |
| Description: The purpose of this research study is to compare how well two different treatments work. In this study, patients will receive either a treatment that includes the investigational drug called brentuximab vedotin or a commonly prescribed treatment that does not contain brentuximab vedotin....MORE |
| ___________________________________________________________________________________________________ |
| Number: 201205103 |
Principal Investigator: DiPersio, John |
| Title: Study of the Anti-EphA3 Monoclonal Antibody KB004 in Subjects with EphA3-Expressing Hematologic Malignancies |
| Description: The main purpose of this clinical research study is to find the highest tolerable dose of the study drug KB004, which is being tested as a possible therapy for people with different
types of blood cancer (leukemia
as well as other blood cancers). This study will also explore whether KB004 is safe fo...MORE |
| ___________________________________________________________________________________________________ |